Law Legalization News Politics U.S.

President Trump Could Ignore Provisions That Protect Medical Cannabis States

Source: Shutterstock

President Trump Signs New $1.4 Trillion Spending Package Avoiding Government Shutdown

Here’s Why Investors Shouldn’t Worry About Trump’s Attached Statement Regarding Legal Medical Cannabis States

On Friday, U.S. President Donald Trump signed into law a new large-scale spending package allowing the United States government to avoid another shutdown before the Christmas holidays. Trump signed the $1.4 trillion funding bill from the comfort of Air Force One as he headed to his Mar-a-Lago resort in Florida, where the President and his family will be spending the holidays.

You may be asking yourself, what does this have to do with cannabis?

The reason this news story is relevant to the cannabis investing community has to do with Trump’s statement attached to the bill regarding the protection of medical cannabis state laws.

In a signing statement, President Trump wrote the following: “Division B, section 531 of the Act provides that the Department of Justice may not use any funds made available under this Act to prevent implementation of medical marijuana laws by various States and territories. My Administration will treat this provision consistent with the President’s constitutional responsibility to faithfully execute the laws of the United States.”

Effectively, what Trump is saying here is that he reserves the right to ignore Division B, section 531 of the congressionally approved legislation that’s purpose is to protect states with legal medical cannabis from interference by the federal government.

Trump’s statement on the medical cannabis provision doesn’t in any way state that he intends to disregard the wish of the United States Congress to prevent the U.S. Department of Justice (DOJ) from being able to prosecute state-legal medical marijuana growers, sellers or patients. However, the President made it clear that his administration believes they still retain the authority to enforce the wildly outdated federal drug law which still lists cannabis as a schedule one narcotic.

To Read The Rest Of This Article By Ryan T. on The Cannabis Investor

Published: December 23, 2019

Cannabis Licensing Scandal Sweeps Pasadena, California
How Cannabis MSOs Are Winning Over Customers In Evolving US Markets
Legal marijuana use still costs people jobs. A new California bill takes on the issue

Leave Your Reply